How many studies have been conducted on Goserelin?

BiohacksAI has indexed 299 PubMed studies on Goserelin, including 96 randomized controlled trials (RCTs). 72% of studies involve human subjects.

What are the main research areas for Goserelin?

The primary research domains for Goserelin are 🔬 Oncology, 🧬 Hormones, 😴 Sleep. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Goserelin

A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer.

299+ PubMed studies analyzed · 96 RCTs · Evidence Score: 58.5

Research Domains

Goserelin has been studied across 19 research domains including 🔬 Oncology, 🧬 Hormones, 😴 Sleep, 💪 Strength & Power, 👁️ Vision & Eye. The primary research focus is 🔬 Oncology with 64% of studies addressing this area.

Loading evidence profile...

This evidence profile for Goserelin is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.